Biotech RadarJobs updated

COMPANY

Avenzo Therapeutics

HQ: San Diego, CA source · avenzotx.com ↗

Clinical Phase 2

11 open jobs · last seen Oct 23, 2026 · 4 sources

Keywords: oncology Solid Tumor Cancer Locally Advanced Urothelial Cancer HR+/HER2- Breast Cancer HR+, HER2-, Advanced Breast Cancer CCNE1 Amplification Epithelial Ovarian Cancer Primary Peritoneal Cancer Fallopian Tube Cancer Endometrial Cancer TNBC - Triple-Negative Breast Cancer Lung Cancers Epithelial Tumor Biliary Tract Cancer Nasopharyngeal Cancers AVZO-021 AVZO-103 AVZO-1418 AVZO-023

Profile checked Oct 10, 2026

11Open jobs4Trials (company is sponsor)

Hiring

TitleLocation (from posting)Employer postedFirst seen
Senior Director, Clinical DevelopmentCorporate Office, San Diego, CA, US; Remote - US, USOct 17, 2026Oct 17, 2026
Director, PharmacometricsSan Diego, CA, US; USOct 7, 2026Oct 11, 2026
Senior/Executive Director, Clin PharmacologyCorporate Office, San Diego, CA, US; Remote - US, USOct 7, 2026Oct 11, 2026
Director, Biologics Process DevelopmentSan Diego, CA, US; USSep 29, 2026Oct 11, 2026
Executive AssistantCA - Corporate Office, San Diego, CA, USSep 29, 2026Oct 11, 2026

See all 11 jobs

Raises and deals from press releases

Raises announced in these releases: $210M disclosed.

From the company’s own releases; this list is partial. All raises and deals

Timeline

  1. Trial start Phase 1/Phase 2: BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001) source ↗
  2. Raise Series B · $60M source ↗
  3. Trial start Phase 1/Phase 2: ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors source ↗
  4. Trial start Phase 1/Phase 2: AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001) source ↗
  5. Raise Series A · amount not disclosed source ↗
  6. Raise Series A · $150M source ↗
  7. Trial start Phase 1/Phase 2: Study of AVZO-021 in Patients With Advanced Solid Tumors source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 4

RecordTitlePhaseStatusStartPrimary completion
NCT07193511BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)Phase 1/Phase 2RecruitingOct 2, 20252030-03 (estimated)
NCT05867251Study of AVZO-021 in Patients With Advanced Solid TumorsPhase 1/Phase 2RecruitingAug 30, 2023Jan 31, 2028 (estimated)
NCT07038343AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)Phase 1/Phase 2RecruitingJun 4, 20252030-06 (estimated)
NCT06998407ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid TumorsPhase 1/Phase 2RecruitingAug 20, 20252028-08 (estimated)

Raises and investors new

Form D raises come from the company’s own SEC filing (last 2 years).

Open jobs 11

TitleLocation (from posting, not HQ)Employer postedFirst seenLevel
Senior Director, Clinical DevelopmentCorporate Office, San Diego, CA, US; Remote - US, USOct 17, 2026Oct 17, 2026Not stated
Director, PharmacometricsSan Diego, CA, US; USOct 7, 2026Oct 11, 2026Senior
Senior/Executive Director, Clin PharmacologyCorporate Office, San Diego, CA, US; Remote - US, USOct 7, 2026Oct 11, 2026Executive
Director, Biologics Process DevelopmentSan Diego, CA, US; USSep 29, 2026Oct 11, 2026Senior
Executive AssistantCA - Corporate Office, San Diego, CA, USSep 29, 2026Oct 11, 2026Mid
Senior Director, Clin Trial SuppliesCorporate Office, San Diego, CA, USSep 19, 2026Oct 11, 2026Senior
Associate Director, Statistical ProgrammingCorporate Office, San Diego, CA, US; Remote - US, USSep 18, 2026Oct 11, 2026Senior
Executive Director, Clinical DevelopmentCorporate Office, San Diego, CA, US; Remote - US, USSep 16, 2026Oct 11, 2026Executive
Director, Data ManagementCorporate Office, San Diego, CA, US; Remote - US, USSep 5, 2026Oct 11, 2026Senior
Human Resources GeneralistCorporate Office, San Diego, CA, USSep 3, 2026Oct 11, 2026Mid
Vice President, Information TechnologyCorporate Office, San Diego, CA, USSep 2, 2026Oct 11, 2026Executive

Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.

Connect

See your connections at Avenzo Therapeutics on LinkedIn (search by name, results not checked)

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-18

Feedback